Dr Adithya (Adi) Balasubramanian is a medical oncologist and clinician scientist based at the Parkville Biomedical Precinct, with a special interest in thoracic cancers.

Adi is dedicated to providing patient-centred care through his role in the thoracic oncology service at the Peter MacCallum Cancer Centre, where he is an investigator for early and late phase clinical trials. He has experience delivering novel therapeutics into clinical practice, including first-in-Australia treatments for thoracic cancers. Collaborating with a multidisciplinary team at the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and Melbourne Private Hospital, Adi ensures patients receive evidence-based care. He is also deeply committed to clear and compassionate communication with patients and their families throughout their cancer journey.

Beyond his clinical work, Adi recently presented his PhD completion seminar at the Walter and Eliza Hall Institute of Medical Research. His doctoral research used CRISPR-Cas9 technology to identify immunotherapeutic targets aimed at improving outcomes for patients with solid organ cancers. In 2023, he was awarded a fellowship to advance his laboratory research at the Wellcome Sanger Institute and the University of Cambridge. Adi’s research has been published in leading journals, including The Lancet Oncology and Journal of Thoracic Oncology. His work has earned him recognition through national and international awards, as well as competitive research grant funding. His focus on integrating research advancements into clinical practice reflects his ongoing commitment to improving care and outcomes for patients with thoracic cancers.